Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Jaclyn Berkley, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about David Gilboa
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Jaclyn Berkley, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.7. David Gilboa appears in 1 tracked Healthcare story from February 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering David Gilboa. Shared-story counts are live from our verified record — not editorial picks.
Warby Parker and Seer, Inc. reported Q4 2025 results, highlighting a pivot toward integrated health platforms and advanced diagnostic capabilities. While Warby Parker expands its telehealth and physical eye care ecosystem, Seer is accelerating the commercialization of its proteomics technology to redefine precision medicine.